l -Carnitine conjugated chitosan-stearic acid polymeric micelles for improving the oral bioavailability of paclitaxel
Autor: | Hailan Mo, Wei Zhang, Tan Yang, Wei Wu, Jianfang Feng, Lanzhen Huang, Qian Zhang |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
Paclitaxel Administration Oral Biological Availability Pharmaceutical Science RM1-950 macromolecular substances 02 engineering and technology Conjugated system 030226 pharmacology & pharmacy Micelle Rats Sprague-Dawley Chitosan 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Carnitine medicine Animals Humans Particle Size Solute Carrier Family 22 Member 5 Micelles Drug Carriers Polymeric micelles technology industry and agriculture General Medicine 021001 nanoscience & nanotechnology l-carnitine Antineoplastic Agents Phytogenic Bioavailability Drug Liberation oral bioavailability Intestinal Absorption chemistry Female lipids (amino acids peptides and proteins) Therapeutics. Pharmacology Stearic acid Caco-2 Cells 0210 nano-technology Stearic Acids Research Article medicine.drug Nuclear chemistry |
Zdroj: | Drug Delivery Drug Delivery, Vol 27, Iss 1, Pp 575-584 (2020) |
ISSN: | 1521-0464 1071-7544 |
Popis: | A delivery system based on l-carnitine (LC) conjugated chitosan (CS)-stearic acid polymeric micelles has been developed for improving the oral bioavailability of paclitaxel (PTX) through targeting intestinal organic cation/carnitine transporter 2 (OCTN2). Stearic acid grafted chitosan (CS-SA), as micelle skeleton material, was synthesized by 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC)-mediated coupling reaction. The PTX-loaded micelles were prepared by solvent evaporation-hydration method, and the ligand LC was conjugated onto the micelle surface by anchoring its derivative stearoyl group to the lipophilic core of micelle. The modified polymeric micelles showed regular spherical shapes with small particle size of 157.1 ± 5.2 nm and high drug loading capacity of 15.96 ± 0.20 wt%, and the micelle stability in water was supported by low critical micelle concentration of 14.31 ± 0.21 μg/ml. The drug-loaded micelles presented a slow and incomplete in vitro release, and the pharmacokinetic studies indicated the micelle carriers increased the relative bioavailability of PTX to 165.8% against the commercial formulation. The enhancement effect on intestinal absorption was also confirmed by the intracellular uptake of Caco-2 cells. The proposed micelle carrier system manifested a prospective tool for oral drug delivery. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |